【摘 要】
:
Human lung cancer is the leading cause of cancer death worldwide.Bevacizumab,a mAb against vascular endothelial growth factor (VEGF),in combination with chemotherapy showed significant therapeutic eff
【机 构】
:
Tumor Immunobiology Program James Graham Brown Cancer Center University of Louisville USA
【出 处】
:
中国上海第七届国际新药发明科技年会
论文部分内容阅读
Human lung cancer is the leading cause of cancer death worldwide.Bevacizumab,a mAb against vascular endothelial growth factor (VEGF),in combination with chemotherapy showed significant therapeutic efficacy in human lung cancer patients.However,increased adverse effects limit its clinical utilization.Previous studies demonstrated that polysaccharide β-glucan significantly augments anti-tumor mAb-mediated efficacy via stimulation of the innate effector neutrophil complement receptor 3 (CR3).Here,we explored combined 1β-glucan with bevacizumab therapy for human lung cancer using murine xenograft models.To that end,human lung adenocarcinomas were screened for membrane-bound VEGF expression.Both subcutaneous and orthotopic lung cancer xenografi models were used to evaluate the combination therapy.We found that PC 14PE6 adenocarcinoma cells express membrane-bound VEGF both in vitro and in vivo.Bevacizumab bound to surface VEGF on PC14PE6 cells and activated complement.In the subcutaneous PC 14PE6 tumor model,β-glucan plus bevacizumab showed augmented efficacy in terms of tumor progression and long-term survival compared to bevacizumab-treated alone.These effects were accompanied with massive complement deposition and neutrophil infiltration within tumors.However,this effect was not observed in surface-bound VEGF-negative human lung tumors.Therapeutic efficacy of β-glucan with bevacizumab was further demonstrated in an orthotopic lung cancer model.Thus,our data suggest that β-glucan enhances bevacizumab-mediated efficacy and may provide therapeutic benefits for lung cancers with membrane-bound VEGF expression.
其他文献
Decline in skeletal muscle mass and function occurs in older men and women.Age-associated loss of muscle increases risk of functional limitations,falls,fractures,loss of independence and poor quality
The growth hormone secretagogue receptor (GHSR) is a GPCR whose natural ligand is the 28 amino acid peptide ghrelin.Ghrelin agonism of the GHSR in the CNS leads to growth hormone (GH) secretion and in
Using genome-wide association-and large-scale replication analyses we have convincingly mapped 30 loci (17 novel) that contribute to variation in lipoprotein concentrations and created a genetic risk
Background:Epidemiological studies suggest that hyperglycemia abrogates gender based cardiovascular protection possibly associated with estrogens.Objectives:The objectives of our study were to investi
Glucose is the main energy source for the mammalian brain.It is transported from the blood to the brain across the endothelial cells of the blood-brain barrier and into the neurons and glia.This trans
Celiac disease is a pathologic immune reaction to ingested gluten proteins of wheat,rye and barley.In subjects with genetic predisposition,gluten-derived gliadin peptides induce chronic intestinal inf
With a 2-3% lifetime risk,endometrial carcinoma (EC) is the most common gynecologic malignancy in developed countries,and the incidence and mortality is increasing.There is hence a major need to devel
Toll-like receptors (TLRs) 7,8,and 9 belong to a family of pathogen-associated molecular pattern (PAMP) recognition receptors.These receptors have been shown to be expressed in endosomal membranes of
The application of vaccines to cancer is nowadays an attractive possibility thanks to advances in molecular engineering and a better understanding of tumor immunology.Transgenic animal models have pla
Inhibition ofT-cell activation is the most efficient way to prevent transplant rejection.Among the immunosuppressants currently on the market,only calcineurin inhibitors (CNIs) inhibit specifically T-